Founded in 1987, Merit Medical manufactures medical devices used in interventional, diagnostic, and therapeutic procedures across radiology, cardiology, breast, vascular, and dialysis specialties. Locally, Merit Medical Australia opened for business in 2016 with an office in Melbourne, followed by an office in Auckland in 2017. Merit Medical ANZ is dedicated to supplying and supporting our customers with best-in-class innovative products, dedicated education offerings, and our commitment to social and environmental responsibility.
For more information, please visit: www.merit.com

For over 50 years, Amoena has been synonymous with innovation, passion and competence in the field of breast care. Our high-quality recovery care products, breast forms and breast care apparel give breast-operated women a visually perfect result with the highest wearing comfort. At Amoena, we know no detail is too small when it comes to helping breast-operated women live confidently. Patents for materials and manufacturing methods are proof of our progress but we’ll never stop endeavouring to meet every need with the highest quality products. Since developing the first breast form, we’ve sold more than 17 million, as well as 30 million pieces of breast care apparel. Today, we are proud to support women throughout their journey – from the moment they are diagnosed, to living life to the fullest once more. We call it The Amoena Solution.
For more information, please visit: www.amoena.com/au

Icon is a leading cancer care organisation with centres across Australia and globally in New Zealand, Singapore, Indonesia, Malaysia, China and the UK. We deliver integrated medical oncology, haematology, radiation oncology, molecular imaging, theranostics and clinical research, aiming to provide the best care possible close to home. Icon Cancer Centre Australia brings together 250+ specialists across 45 centres, offering multidisciplinary expertise. We provide comprehensive breast cancer treatment, including chemotherapy, hormone and targeted therapies, supported by advanced radiation techniques such as stereotactic approaches, SGRT for tattooless positioning and DIBH for improved patient outcomes. Our teams are committed to personalised, high-quality care.
LinkedIn: @Icon Cancer Centre – Australia & New Zealand
For more information, please visit: iconcancercentre.com.au/

Surgeons Choice (Australia) Pty Ltd is a trusted and innovative provider of high-quality surgical and medical solutions, dedicated to supporting healthcare professionals across Australia. Established with a commitment to excellence and patient safety, we specialise in sourcing and distributing premium surgical instruments, medical devices, and consumables from leading international manufacturers.
Our mission is to empower surgeons and healthcare providers with reliable, cutting-edge tools that enhance precision, efficiency, and outcomes in clinical environments. Surgeons Choice takes pride in its strong partnerships with hospitals, surgical centres, and clinics, delivering tailored solutions backed by responsive service and deep industry expertise.
At Surgeons Choice, quality, integrity, and innovation drive everything we do. We remain committed to advancing Australian healthcare through superior products and a client-first approach.
For more information, please visit: www.surgeonschoice.com.au

Swiss company Stratpharma has developed breakthrough treatments for faster wound healing and abnormal scar prevention and many of these treatments are suitable for patients going through cancer treatments. StrataXRT is a wound dressing clinically proven to prevent and treat radiation dermatitis. StrataCTX uses the same formulation as StrataXRT and is designed as a steroid sparing gel to treat cutaneous rashes caused by chemotherapy and is also ideal for healing the skin post 5FU treatment. Stratamed is a self-drying wound dressing that can be applied to open wounds and compromised skin. Strataderm is Australia’s most trusted scar gel and when applied once daily, prevents and treats abnormal scars.
For more information please visit: www.stratpharma.com
Call 1800 567 007 or email: au.order@stratpharma.com

Since 1992, Device Technologies has been dedicated to improving patients’ lives through leading edge technology and services. Successfully supplying hospitals and healthcare professionals with the finest medical solutions for their patients, we continue to grow, with over 200 trusted brands over 1000 highly skilled staff throughout Australia, New Zealand, and Asia.
Behind every brand distributed by Device Technologies is the concept that we are delivering leading technology into the most capable hands. We nurture the relationship between distributor and healthcare professionals, guiding the process from concept to delivery and ongoing support with training and technical service specialty teams.
For more information, please visit: www.device.com.au

Genomic Diagnostics is the nationally coordinated genetic testing service for Healius Pathology. As a leader in diagnostic genomics, we are committed to supporting breast cancer specialists—including oncologists, breast care nurses and surgeons—with vital hereditary breast and ovarian cancer genetic testing. Our advanced technology provides critical insights into BRCA1, BRCA2, and other cancer-related genes, helping identify patients at higher risk and enabling personalised care. With an expert team dedicated to delivering timely, high-quality results, we empower and support healthcare professionals and their patients to make informed decisions.
For more information, please visit: www.genomicdiagnostics.com.au

Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan with over 120 years of innovation, is expanding its Australian presence. Our mission: to redefine cancer treatment through our proprietary antibody drug conjugate (ADC) technology, aiming to become a global top ten in oncology by 2030.
In Australia, we’re building a dedicated team, conducting 18 clinical trials at 47 sites evaluating our DXd ADCs*, and working to bring their benefits to patients sooner. Our pipeline of ADCs and novel entities targets difficult-to-treat cancers including breast, lung, gastric, ovarian, and endometrial. We are committed to partnering with researchers, clinicians, patients, patient advocates and government to deliver our mission.
*does not include other assets
For more information please visit: astrazeneca.com.au

Breast Surgeons of Australia and New Zealand (BreastSurgANZ) is the peak professional membership society representing specialist breast surgeons who manage benign and malignant breast disease across Australia and Aotearoa New Zealand. The Society sets and upholds post-Fellowship training standards and promotes excellence in patient care through education, quality audit, research, and the advancement of evidence-based surgical practice.
For more information please visit: www.breastsurganz.org

The Australasian Society for Breast Disease (ASBD) is a multidisciplinary society for health professionals with an interest in the prevention, diagnosis, treatment and research aspects of breast disease.
ASBD was incorporated in 1997 and in 2022 celebrated its 25th Anniversary. We welcome membership from all health professionals with an interest in the multidisciplinary approach to breast cancer.
VISION: Better breast health outcomes in Australia and New Zealand.
PURPOSE: We support health professionals to achieve better health outcomes
For more information please visit: www.asbd.org.au

At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers’ toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients’ lives for the better while enabling healthcare professionals to perform at their best. Because people, and their wellbeing, are at the heart of every scientific advancement we pursue. We partner closely with the brightest minds in healthcare to ensure that every solution we create melds the latest technology with compassion and empathy. Because at Solventum, we never stop solving for you.
For more information click here: Enabling better, smarter, safer healthcare | Solventum

GenesisCare is a proudly Australian-run cancer care provider, specialising in radiation therapy with a growing footprint in medical oncology, theranostics and personalised medicine. Our relentless pursuit for better care is reflected in our modern treatment techniques, technology and contemporary service experience. Our dedicated doctors and research team partner globally to be first movers in bringing clinical innovations to patients close to home. Around 30,000 people a year entrust us with their care across 50 locations nationally.
For more information please visit: www.genesiscare.com/au

Cirdan is a leading provider of healthcare informatics and imaging solutions designed to support and accelerate patient diagnosis. With operations in the United Kingdom, Australia and Canada, we are proud to support breast clinicians both across Australia and internationally.
We are committed to helping surgeons reduce re-operation rates through rapid, high-quality imaging at the point of care. Our solutions support both core biopsy and surgical specimen assessment, enabling faster clinical decision-making in theatres.
Solas OR delivers high-resolution imaging with seamless workflow integration, helping clinical teams manage cases accurately and efficiently.
For more information please visit: www.cirdan.com

MENTOR™ Australia, a business unit of Johnson & Johnson Medical Pty Ltd, is a global leader in breast aesthetics with a heritage dating back to 1969. With over 40 years dedicated to Breast Augmentation and Reconstruction innovation, MENTOR™ continues to advance science driven design, rigorous testing, and high quality implant solutions. The company supports surgeons through a patient first philosophy, offering extensive clinical evidence, trusted products, and professional education resources, including webinars and surgeon training through the Johnson & Johnson Institute. This commitment enables surgeons to deliver optimal, confident outcomes for their patients
For more information please visit: https://breastimplantsbymentor.net/en-AU/home

Veracyte is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development.
For more information please visit: www.veracyte.com/

Breast Cancer Network Australia (BCNA) is the peak national organisation for Australians affected by breast cancer with more than 120,000 members. Representing the people behind the statistics, BCNA works to ensure the voices of everyday Australians affected by breast cancer are heard and that they receive the very best support, information, treatment and care appropriate to their individual needs.
For more information please visit: www.bcna.org.au

Novartis is improving the lives of more than 2.5 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare.
We are reimagining medicine by using innovative science and technology to address challenging healthcare issues and our rich research pipeline has 50+ ongoing Phase III programs. We are transforming how clinical trials are run to increase patients’ access to our industry-leading clinical trials footprint in Australia.
For more information please visit: www.novartis.com/au-en/